Target intelligence / Profile preview

Trypanothione Reductase

Molecular classification
Enzyme, Oxidoreductase, Flavoenzyme
01

Overview

Trypanothione reductase is an essential flavoenzyme unique to kinetoplastid protozoa that maintains cellular redox balance via reduction of trypanothione disulfide using electrons from NADPH through its FAD cofactor. Its absence or inhibition leads to parasite death due to oxidative damage. Because there are no close human homologs, it represents an ideal selective drug target against diseases like leishmaniasis and Chagas' disease. Multiple structural studies have revealed both active site and novel allosteric pockets suitable for rational drug design efforts.

02

Mechanism of action

Inhibition of trypanothione reductase, leading to oxidative stress and parasite death

03

Biological functions

Redox homeostasisAntioxidant defense
04

Disease associations

Chagas' diseaseAfrican sleeping sicknessLeishmaniasis
05

Safety considerations

Selectivity for parasite enzyme over human homologs is crucial to minimize off-target effects
06

Interacting drugs

Tricyclic compounds (acridines, phenothiazines)

2 more in the full profile.

Beyond the preview

Go deeper on Trypanothione Reductase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trypanothione Reductase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call